Veklury-Dexamethasone Combo Safely Treats COVID-19 in 3 MG Patients

Veklury-Dexamethasone Combo Safely Treats COVID-19 in 3 MG Patients

293725

Veklury-Dexamethasone Combo Safely Treats COVID-19 in 3 MG Patients

Three patients with myasthenia gravis (MG) were safely treated for COVID-19 with a combination of the antiviral medication Veklury (remdesivir) and the anti-inflammatory dexamethasone, while having no apparent worsening of their MG symptoms. Veklury was the first medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of COVID-19. “Considering the current practice of coadministering dexamethasone and remdesivir in COVID-19 patients requiring supplemental oxygen, we believe our findings suggest that remdesivir [Veklury]…

You must be logged in to read/download the full post.